NCT06383806 Decreasing Nightmares in Adults With Narcolepsy
| NCT ID | NCT06383806 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Narcolepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-07-01 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
Eligibility Criteria
PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES Inclusion Criteria: * Diagnosis of narcolepsy type 1 or narcolepsy type 2 * Nightmare frequency of ≥1 times per week * Age 18 or older * Able to speak, read, and write in English * Live in the United States * Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study Exclusion Criteria: * Currently engaged in trauma- or sleep-related psychotherapy * Previous behavioral treatment for nightmares * Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment * Untreated moderate-severe sleep apnea PARTICIPANTS WHO ARE PARTNERS OF SOMEONE WITH NARCOLEPSY Inclusion Criteria: * Live with a romantic partner who meets the above criteria and has agreed to participate in the study * Age 18 or older * Able to speak, read, and write in English * Live in the United States
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06383806 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Narcolepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06383806 currently recruiting?
Yes, NCT06383806 is actively recruiting participants. Contact the research team at DAWNstudy@utah.edu for enrollment information.
Where is the NCT06383806 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT06383806 clinical trial?
NCT06383806 is sponsored by University of Utah. The trial plans to enroll 80 participants.